These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38001039)

  • 1. Use of Transcriptional Signatures to Differentiate Pathogen-Specific and Treatment-Specific Host Responses in Patients With Bacterial Bloodstream Infections.
    Thaden JT; Ahn R; Ruffin F; Gjertson DW; Hoffmann A; Fowler VG; Yeaman MR
    J Infect Dis; 2024 May; 229(5):1535-1545. PubMed ID: 38001039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
    Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia.
    Parmar R; Pickering H; Ahn R; Rossetti M; Gjertson DW; Ruffin F; Chan LC; Fowler VG; Yeaman MR; Reed EF;
    Front Immunol; 2024; 15():1373553. PubMed ID: 38846955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).
    Hu F; Yuan L; Yang Y; Xu Y; Huang Y; Hu Y; Ai X; Zhuo C; Su D; Shan B; Du Y; Yu Y; Lin J; Sun Z; Chen Z; Xu Y; Zhang X; Wang C; He L; Ni Y; Zhang Y; Lin D; Zhu D; Zhang Y
    Front Cell Infect Microbiol; 2022; 12():1075185. PubMed ID: 36590586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus Causing Bloodstream Infections at Ruijin Hospital in Shanghai from 2013 to 2018.
    Gu F; He W; Xiao S; Wang S; Li X; Zeng Q; Ni Y; Han L
    Sci Rep; 2020 Apr; 10(1):6019. PubMed ID: 32265473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.
    Dat VQ; Vu HN; Nguyen The H; Nguyen HT; Hoang LB; Vu Tien Viet D; Bui CL; Van Nguyen K; Nguyen TV; Trinh DT; Torre A; van Doorn HR; Nadjm B; Wertheim HFL
    BMC Infect Dis; 2017 Jul; 17(1):493. PubMed ID: 28701159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality, virulence genes, and antibiotic resistance of Staphylococcus aureus isolated from blood in Shandong, China.
    Wang X; Lin D; Huang Z; Zhang J; Xie W; Liu P; Jing H; Wang J
    BMC Microbiol; 2021 Oct; 21(1):281. PubMed ID: 34657588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
    Foglia F; Della Rocca MT; Melardo C; Nastri BM; Manfredini M; Montella F; De Filippis A; Finamore E; Galdiero M
    Pathog Glob Health; 2023 Jun; 117(4):381-391. PubMed ID: 36190133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
    Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence gene profiling and molecular characterization of hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection.
    Yu F; Li T; Huang X; Xie J; Xu Y; Tu J; Qin Z; Parsons C; Wang J; Hu L; Wang L
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):363-8. PubMed ID: 23021064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
    Zhanel GG; DeCorby M; Adam H; Mulvey MR; McCracken M; Lagacé-Wiens P; Nichol KA; Wierzbowski A; Baudry PJ; Tailor F; Karlowsky JA; Walkty A; Schweizer F; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4684-93. PubMed ID: 20805395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
    Jean SS; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.